These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25005553)

  • 1. Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia.
    Chou KJ; Chen HK; Hung CH; Chen TT; Chen CM; Wu BJ
    Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):249-57. PubMed ID: 25005553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients.
    Chen HK; Lan TH; Wu BJ
    Eur Arch Psychiatry Clin Neurosci; 2013 Feb; 263(1):75-82. PubMed ID: 22729212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.
    George TP; Vessicchio JC; Sacco KA; Weinberger AH; Dudas MM; Allen TM; Creeden CL; Potenza MN; Feingold A; Jatlow PI
    Biol Psychiatry; 2008 Jun; 63(11):1092-6. PubMed ID: 18096137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of successful smoking cessation: convergent genome-wide association study results.
    Uhl GR; Liu QR; Drgon T; Johnson C; Walther D; Rose JE; David SP; Niaura R; Lerman C
    Arch Gen Psychiatry; 2008 Jun; 65(6):683-93. PubMed ID: 18519826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Hartmann-Boyce J; Cahill K; Lancaster T
    Cochrane Database Syst Rev; 2012 Nov; 11():CD000146. PubMed ID: 23152200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
    Siskind DJ; Wu BT; Wong TT; Firth J; Kisely S
    Lancet Psychiatry; 2020 Sep; 7(9):762-774. PubMed ID: 32828166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study.
    Caponnetto P; Auditore R; Russo C; Cappello GC; Polosa R
    Int J Environ Res Public Health; 2013 Jan; 10(2):446-61. PubMed ID: 23358230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do atypical antipsychotics really enhance smoking reduction more than typical ones?: the effects of antipsychotics on smoking reduction in patients with schizophrenia.
    Wu BJ; Chen HK; Lee SM
    J Clin Psychopharmacol; 2013 Jun; 33(3):319-28. PubMed ID: 23609378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
    Johnson M; Anderson P; Lockhart I
    BMC Fam Pract; 2014 Mar; 15():47. PubMed ID: 24645823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes from an outpatient smoking-cessation clinic.
    Roth MT; Andrus MR; Westman EC
    Pharmacotherapy; 2005 Feb; 25(2):279-88. PubMed ID: 15767242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of smoking reduction outcomes in a sample of 287 patients with schizophrenia spectrum disorders.
    Wu BJ; Lan TH
    Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):63-72. PubMed ID: 26310877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
    Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
    J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.
    Blondal T; Gudmundsson LJ; Tomasson K; Jonsdottir D; Hilmarsdottir H; Kristjansson F; Nilsson F; Bjornsdottir US
    Addiction; 1999 Jul; 94(7):1007-15. PubMed ID: 10707439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Effectiveness of Pharmaceutical Smoking Cessation Aids: Time-Varying Effects.
    Chaiton M; Diemert LM; Bondy SJ; Cohen JE; Fung MD; Zhang BR; Ferrence RG
    Nicotine Tob Res; 2020 Apr; 22(4):506-511. PubMed ID: 30260455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.